Literature DB >> 464123

Nonpressor mechanisms in CNS-induced natriuresis.

D R Mouw, A J Vander, J J Bourgoignie, S S Kutschinski, N P Mathias.   

Abstract

Ventriculocisternal perfusion was performed in pentobarbital-anesthetized dogs. Perfusion of high Na (300 mM NaCl) artificial cerebrospinal fluid (CSF) (E) for 2 h was preceded by 2 h of control (C) and was followed by 2 h of recovery (R) during which normal (150 mM NaCl) artificial CSF was perfused. A time-control group was perfused with normal artificial CSF throughout C, E, and R. High sodium perfusion resulted in a marked natriuresis in each of nine animals and suppression of plasma renin activity. Theere were no simultaneous changes in mean arterial pressure, glomerular filtration rate, or renal plasma flow. Sodium excretion and plasma renin activity showed a slight gradual rise in the time-control group, but no significant differences were observed between the C and E periods; sodium excretion and plasma renin activity were similar in the high Na and time-control groups during C and R, but significantly different during E. It is concluded that when CSF sodium is elevated by perfusing artificial CSF, the resulting natriuresis and suppression of plasma renin activity are not caused by hemodynamic changes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464123     DOI: 10.1152/ajprenal.1979.237.2.F157

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Lack of evidence for a cerebral sodium modulating mechanism in the monkey.

Authors:  A P Wu; J P Gilmore
Journal:  Basic Res Cardiol       Date:  1987 Jul-Aug       Impact factor: 17.165

2.  Cerebral regulation of renal sodium excretion in sheep infused intravenously with hypertonic NaCl.

Authors:  A Chodobski; M J McKinley
Journal:  J Physiol       Date:  1989-11       Impact factor: 5.182

Review 3.  Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors.

Authors:  John M Hamlyn
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-03       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.